Condensed Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 14,469,744	$ 12,710,762
Collaboration receivable		5,000,000
Prepaid expenses	666,318	1,094,229
Other current assets	65,061	9,283,625
Total current assets	15,201,123	28,088,616
Property and equipment, net	101,582	114,112
Other assets:
Goodwill	7,647,267	7,647,267
Other non-current assets	292,918	406,956
Total assets	23,242,890	36,256,951
Current liabilities:
Accounts payable	3,491,991	1,405,734
Accrued expenses	5,567,964	2,428,193
Deferred collaboration funding, current	6,340,438	15,825,938
Other current liabilities	185,265	9,450,085
Bridge loan payable, current, at fair value	1,887,606
Total current liabilities	17,473,264	29,109,950
Deferred collaboration funding, non-current	7,868,731	8,661,109
Bridge loan payable non-current, at fair value	2,197,103
Convertible note payable, at fair value	4,321,200
Other non-current liabilities	166,134	209,497
Total liabilities	32,026,432	37,980,556
Commitments and Contingencies (Note 8)
Stockholders’ deficit:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 15,672,791 and 14,310,244 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	1,567	1,431
Additional paid-in capital	117,570,885	112,784,918
Accumulated deficit	(126,355,994)	(114,509,954)
Total stockholders’ deficit	(8,783,542)	(1,723,605)
Total liabilities and stockholders’ deficit	$ 23,242,890	$ 36,256,951